Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,469.6 Cr 3.5% -0.9% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr 1.7% -5.7% -7.4% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr 0.8% -6.7% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr 0.6% 4.3% 24.4% Stock Analytics
CIPLA ₹106,048.0 Cr -4.7% -12.3% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 6.3% -2.1% -4.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.5%

-0.9%

31.4%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses